Plegridy(TM) marketing applications accepted for review

A board to discuss the Multiple Sclerosis modifying drug Plegridy
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Plegridy(TM) marketing applications accepted for review

Post by MSUK » Mon Jul 22, 2013 6:56 am

US and EU regulatory authorities accept Plegridy(TM) (peginterferon beta-1a) marketing applications for review

Biogen Idec announced that U.S. and EU regulatory authorities have accepted the marketing applications for the review of Plegridy(TM) (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis (MS). The U.S. Food and Drug Administration (FDA) has accepted Biogen Idec's Biologics License Application (BLA) for marketing approval of PLEGRIDY in the United States and granted the company a standard review timeline. The Marketing Authorisation Application (MAA) of Plegridy for review in the European Union was also validated by the European Medicines Agency...... Read More - http://www.ms-uk.org/index.cfm/PEGylatedinterferonbeta
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post